Klinisch orientierter Schwerpunkt
FB 04 - Universitätsmedizin / Johannes Gutenberg-Universität Mainz
Leinert, Elena; Schwentner, Lukas; Blettner, Maria et al.
Association between cognitive impairment and guideline adherence for application of chemotherapy in older patients with breast cancer: Results from the prospective multicenter BRENDA II studyBREAST JOURNAL. Bd. 25. H. 3. 2019 S. 386-392
Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik Paul et al.
Association of MAPK signaling subtypes with prognostic benefit for bevacizumab in left-sided metastatic colorectal cancer (mCRC) patients treated with FOLFIRI plus cetuximab / bevacizumab (FIRE-3 trial).JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Miller-Phillips, Lisa; Heinemann, Volker; Stahler, Arndt et al.
Association of microRNA-21 with efficacy of cetuximab in RAS wild-type patients in the FIRE-3 study (AIO KRK-0306) and microRNA-21's influence on gene expression in the EGFR signaling pathway.JOURNAL OF CLINICAL ONCOLOGY. Bd. 37. H. 15. 2019
Heimes, Anne-Sophie; Schmidt, Marcus
Atezolizumab for the treatment of triple-negative breast cancerEXPERT OPINION ON INVESTIGATIONAL DRUGS. Bd. 28. H. 1. 2019 S. 1-5
Mueller, Sabine; Farag, Iva; Weickert, Joachim et al.
Benchmarking Wilms' tumor in multisequence MRI data: why does current clinical practice fail? Which popular segmentation algorithms perform well?JOURNAL OF MEDICAL IMAGING. Bd. 6. H. 3. 2019
Stoessel, S.; Neu, M. A.; Wingerter, A. et al.
Benefits on Muscular and Walking Performance from Combined Resistance and Endurance Training During Intensive Cancer Treatment in Pediatric Oncology: Results from the Randomized Controlled Mucki-TrialPEDIATRIC BLOOD & CANCER. Bd. 66. 2019 S. S148-S148
Stewen, K; Theis, S; Teifke, A et al.
Benigne und präinvasive Läsion der BrustFrauenheilkunde up2date. Bd. 13. H. 5. 2019 S. 423-439
Singer, Susanne
Better Capture of the Quality of Life of Patients with Head and Neck Cancers International Study led by the University Medical Center Mainz has developed a new QuestionnaireHNO. Bd. 67. H. 4. 2019 S. 281-281
De Gramont, A.; Henriques, J.; Baruch, B. et al.
Bevacizumab plus oxaliplatin-based chemotherapy as adjuvant treatment for colon cancer (CC): Updated analysis of stage II disease from the AVANT phase III randomized trial by the GERCOR groupANNALS OF ONCOLOGY. Bd. 30. 2019
Galle, Peter R.; Foerster, Friedrich; Kudo, Masatoshi et al.
Biology and significance of alpha-fetoprotein in hepatocellular carcinomaLIVER INTERNATIONAL. Bd. 39. H. 12. 2019 S. 2214-2229